Colofac
In brief
For bowel cramps associated with irritable bowel syndrome, mebeverine helps relax intestinal smooth muscle. Its antispasmodic action is aimed at easing cramping pain. It does not treat every cause of abdominal discomfort.
INN And Brand Names
The International Nonproprietary Name (INN)
ATC Code And Dosage Forms
The ATC Code
| Form | Strength | Typical Dosing |
|---|---|---|
| Standard tablets | 135 mg | 1 tablet, three times daily |
| Modified-release capsules | 200 mg | 1 capsule, twice daily |
| Oral liquid | Equivalent to tabs | As needed for swallowing difficulties |
Manufacturers
The main producer for Colofac in Canada is Abbott Laboratories
Registration Status
Colofac is available both as an over-the-counter (OTC)
Dosage & Administration of Colofac
When it comes to managing Irritable Bowel Syndrome (IBS), finding the right dosage is crucial. The usual adult dosage for Colofac is straightforward: 135 mg three times daily or a 200 mg modified-release capsule taken twice daily. This allows for effective symptom control for many users.
Adjustments for Age and Comorbidities
Most adults will follow this standard dosage. However, certain factors may require careful consideration. For older adults or those with liver or kidney impairments, there aren’t specific formal adjustments required, but it’s wise to use caution and monitor the patient’s response to the medication closely.
Treatment Duration and Storage Guidelines
The duration of Colofac treatment can vary. Patients may find themselves on it for weeks or even months, depending on symptom severity and persistence. It’s recommended to revisit healthcare providers if symptoms continue after two weeks to reassess the treatment plan. When it comes to storage, keep Colofac safely in its original packaging, away from moisture, and at a temperature below 25°C for optimal efficacy.
Safety & Warnings for Colofac
Before starting Colofac, be aware of several important safety guidelines. Absolute contraindications include any known hypersensitivity to mebeverine, as well as conditions like paralytic ileus and specific metabolic disorders such as hereditary galactose intolerance.
Common Side Effects
Every medication comes with the potential for side effects. With Colofac, most users report mild effects including headaches and dizziness, as well as moderate gastrointestinal issues like diarrhea and constipation. Serious side effects are rare but can include adverse allergic reactions that should prompt immediate medical attention.
Special Precautions
For those with severe liver or kidney issues, or women who are pregnant, it’s advised to use Colofac with caution. Though data on breastfeeding is limited, avoiding the medication during this period is generally recommended for precautionary reasons.
Patient Experience with Colofac
Subjective Insights
- Dicyclomine (Bentyl)
- Hyoscine butylbromide (Buscopan)
- Peppermint oil (Colpermin)
Comparison Table of Antispasmodics
| Drug Name | Form | Cost Range (CAD) | Efficacy | Availability |
|---|---|---|---|---|
| Colofac | Tablets, caps | $12 – $30 | High | OTC/Rx |
| Dicyclomine | Caps | $10 – $25 | Moderate | Rx |
| Hyoscine Butylbromide | Tablets | $15 – $35 | Moderate | Rx |
| Peppermint Oil | Capsules | $8 – $20 | Low | OTC |
Doctor Preferences for Colofac
Local practitioners often recommend Colofac for its targeted action, particularly due to the lower risk of sedation compared to other anticholinergics. This preference further emphasizes its safety profile, making it a go-to choice for many addressing gastrointestinal spasms and discomfort.
Market Overview for Colofac in Canada
Understanding where to find Colofac is essential for effective treatment. It is commonly available in major pharmacy chains like Catena and HelpNet, as well as various online platforms. This convenience enhances accessibility for those needing relief.
Average Pricing for Colofac
The average retail price for Colofac ranges from $12 to $30 CAD, depending on the dosage and the retailer. This cost-effectiveness places it as an attractive option for those in need of antispasmodic therapy.
Packaging Details and Demand Patterns
Colofac is offered in blister packs and bottles, designed to protect the contents from light and moisture. Increased demand for this medication has been noted during seasonal gastrointestinal disruptions. Additionally, the rise in chronic conditions post-pandemic has contributed to its growing popularity.
Current Research Trends for Colofac
Clinical trials are currently underway that evaluate the efficacy and safety of Colofac in diverse populations, with a specific focus on long-term effects and gut motility. This ongoing research is expected to further substantiate its role in gastrointestinal treatment.
Experimental Uses of Mebeverine
Recent studies have begun to explore the potential for off-label uses of mebeverine, particularly in conditions like functional dyspepsia and other gastrointestinal disorders. These findings might open doors for broader applications beyond what is typically prescribed.
Patent Expiry and Generics
The current patents surrounding Colofac are nearing expiry, which will likely lead to an influx of generic options in the market. This development is anticipated to enhance competition and provide more affordable options for patients in need of antispasmodic treatment.
